Capital Market Assumptions Suggest Stretched Equity Valuations
For at least the next decade, plan sponsors will likely have to navigate an environment in which largely positive macroeconomic...
Equity
Insight/Low%20Res%20Insight%20Headers/gold%20mining.png "2025 M&A and Equity Capital Markets Insights")
2025 M&A and Equity Capital Markets Insights
Driven by record commodity prices, the mining sector in 2025 recorded its strongest year for mergers and acquisitions (M&A) since...
Korea’s Medipost, success story of tech-focused private equity firms Crescendo, Skylake
Skylake Equity Partners Ltd. and Crescendo Equity Partners Ltd. surprised the South Korean private equity (PE) industry by acquiring Medipost...
U.S. equity returns in 2025: Record-breaking resilience
January 8, 2026 Kelly Bogdanova Vice President, Portfolio AnalystPortfolio Advisory Group – U.S. The U.S. equity market delivered its third...
Global equity capital markets recover while IPO pipeline faces shutdown impact
NEW YORK and LONDON, Dec. 22, 2025 /PRNewswire/ -- Global equity capital markets staged a recovery in 2025, with issuance rising...
Asia’s strong equity deals pipeline to be tested by AI bubble concerns in 2026
By Kane Wu, Vibhuti Sharma and Yantoultra Ngui HONG KONG/MUMBAI, Dec 5 (Reuters) - A strong pipeline of high-profile IPOs...
U.S. Equity Capital Markets
This material (including market commentary, market data, observations or the like) has been prepared by personnel in the Investment Banking...
NRx Pharmaceuticals, Inc. to Present at Noble Capital Markets October 2025 Emerging Growth Virtual Equity Conference
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", or the "Company"), a clinical-stage biopharmaceutical company, and HOPE Therapeutics, Inc., ("HOPE," or...
Hudson Global, Inc. and Star Equity Holdings, Inc. Complete Merger, Forming Diversified Holding Company
OLD GREENWICH, Conn., Aug. 22, 2025 (GLOBE NEWSWIRE) -- Hudson Global, Inc. (Nasdaq: HSON) (“Hudson Global” or “the Company”), a leading...
